Wild West duel game New drug for cystic fibrosis! EC approves Symkevi combined with Kalydeco for children aged 6-11 years The Lancet publishes early ...
INR:1058. leganes vs real madrid Big news! FDA approves breakthrough therapy for cystic fibrosis in just three months The director of the National Medical ...
iran national football team vs qatar national football team matches Top 10 most anticipated new drugs to be launched in 2021 ...
According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.
Krystal Biotech's VYJUVEK, a groundbreaking gene therapy for DEB, achieved $83.8M in Q3 2024 sales. Read why I rate KRYS ...
Researchers at National Jewish Health and colleagues have completed the first study comparing lung macrophages in multiple ...
In STAT's "jealousy list" for 2024, STAT staffers explain what makes a selection of stories they read in other publications ...
A $42,000 grant from NASA and INBRE will further CF research, through a collaborative effort spanning to India and the United Kingdom.
The Food and Drug Administration (FDA) has approved Alyftrek ™ (vanzacaftor/tezacaftor/deutivacaftor) for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one ...
Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company, recently shared his outlook for the stock ...
Changing Futures, a nonprofit dedicated to advancing cystic fibrosis (CF) research, will hold a polar plunge at noon New Year ...
Vertex has won two cystic fibrosis approvals from the FDA, but the agency included high-level safety warnings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback